Skip to main content
. 2010 Sep-Dec;2(3):203–211. doi: 10.4103/0974-777X.68525

Table 3.

Prevalence of infectio us disease markers in the study population (n=1,200)

Infectious disease markers Frequency Percentage (%)
HBsAg 67 5.58
Anti-HCV 5 0.42
Anti-HIV 63 5.25
VDRL 69 5.75
Total 204 17.0